greater-china
(3)
Meixin (MX) Global
Meixin (MX) Global is a New York-based cross-border financial technology and wealth-management platform founded in 2015. It connects Asian wealth managers, independent advisors, private funds and family offices with a curated menu of global alternative investments - real estate debt and preferred equity, hedge funds, private equity, private debt and more - backed by tech-enabled infrastructure for asset analysis, due diligence, custody and reporting. Positioned as a turnkey asset-management platform for the Greater China wealth ecosystem, the company has reported over $2 billion in assets under administration and 1,600+ investable products.
Kimberly Nearing
Kimberly Nearing is the Chief Business Officer of MaveriX Oncology, a Palo Alto biotech building tumor-selective small molecule drug conjugates. She is a Venture Partner at BVCF (Bioveda China Fund) and spent over a decade as Managing Director and Head of Life Sciences at the Hong Kong-based Cedrus Group, building bridges for capital and deals between the U.S., Europe, and Greater China. With early operating years at Amgen, Merck, and IBM Healthcare and a master's from Harvard, she pairs deep biotech operating experience with the relationships that move money across the Pacific.
Peter Cray
Peter Cray is VP Strategy & Operations for AWS Sales, Marketing and Global Services at Amazon Web Services, where he oversees go-to-market strategy, business and sales operations, competitive strategy, and field marketing across 122 subsidiaries worldwide. With nearly three decades in enterprise technology, he spent 15 years at Microsoft in increasingly senior roles - including COO & Chief Business Officer for Microsoft China & Greater China Region - before joining AWS in 2022. He reports to Greg Pearson as part of AWS's integrated global sales organization alongside peers Dave Levy and Robert Chu.